Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 [Leucine aminopeptidase (arylamidase) activity in the serum. Determination using leucine-p-nitroanilide as substrate].

× No keyword cloud information.

43 in total

1. Clinical value of serum leucine aminopeptidase determinations.

Authors: B M BANKS; E P PINEDA; J A GOLDBARG; A M RUTENBURG
Journal: N Engl J Med Date: 1960-12-22 Impact factor: 91.245

2. [ON THE ROLE OF PROTEOLYTIC ENZYMES IN PREGNANCY. I. LEUCINE AMINOPEPTIDASE ACTIVITY OF THE BLOOD SERUM AND PLACENTA].

Authors: B ZSOLNAI; J SOMOGYI; Z SZARVAS; E PUSKAS
Journal: Acta Chir Acad Sci Hung Date: 1964

3. [ON AMINO ACID ARYLAMIDASE (SO-CALLED LEUCINE AMINOPEPTIDASE) ACTIVITY IN THE HUMAN SERUM].

Authors: W NAGEL; F WILLIG; F H SCHMIDT
Journal: Klin Wochenschr Date: 1964-05-01

4. [The heterogenecity of leucine aminopeptidase. Studies on the organs and serum in liver, biliary tract and pancreatic diseases].

Authors: B SCHOBEL; F WEWALKA
Journal: Klin Wochenschr Date: 1962-10-15

5. The measurement of activity of leucine aminopeptidase in serum, urine, bile, and tissues.

Authors: J A GOLDBARG; E P PINEDA; A M RUTENBURG
Journal: Am J Clin Pathol Date: 1959-12 Impact factor: 2.493

6. Serum leucine aminopeptidase in carcinoma of pancreas and other diseases.

Authors: A L MILLER; L WORSLEY
Journal: Br Med J Date: 1960-11-12

7. Comparative study of serum leucine aminopeptidase, 5-nucleotidase and non-specific alkaline phosphatase in diseases affecting the pancreas, hepatobiliary tree and bone.

Authors: O D KOWLESSAR; L J HAEFFNER; E M RILEY; M H SLEISENGER
Journal: Am J Med Date: 1961-08 Impact factor: 4.965

8. [The clinical evaluation of leucine aminopeptidase determination in the serum].

Authors: T MUELLNER; A NEUMAYR; H PIETSCHMANN
Journal: Wien Klin Wochenschr Date: 1962-05-04 Impact factor: 1.704

Review 9. [Clinical-chemical studies in liver diseases].

Authors: F H Kreutz
Journal: Internist (Berl) Date: 1966-01 Impact factor: 0.743

10. LEUCINE AMINOPEPTIDASE IN HUMAN SERUM: COMPARISON OF HYDROLYSIS OF L-LEUCYLGLYCINE AND L-LEUCYL-BETA-NAPHTHYLAMIDE.

Authors: G A FLEISHER; M PANKOW; C WARMKA
Journal: Clin Chim Acta Date: 1964-03 Impact factor: 3.786

4 in total

1. Structure and activity of CPNGRC: a modified CD13/APN peptidic homing motif.

Authors: Leigh A Plesniak; Bridget Salzameda; Holly Hinderberger; Elizabeth Regan; James Kahn; Stephen A Mills; Peter Teriete; Yong Yao; Patricia Jennings; Francesca Marassi; Joseph A Adams
Journal: Chem Biol Drug Des Date: 2010-03-30 Impact factor: 2.817

2. [Urine leucine aminopeptidase in kidney diseases].

Authors: E Luckmann; F Körner
Journal: Klin Wochenschr Date: 1972-11-01

3. [On the behavior of the so-called leucine aminopeptidase (LAP) in the serum during the application of various substrates].

Authors: G Brunner; J Sommer; R Kattermann
Journal: Klin Wochenschr Date: 1968-05-15

4. The contribution of serum enzymes and carcinoembryonic antigen to the early diagnosis of metastatic colorectal cancer.

Authors: E H Cooper; R Turner; L Steele; A M Neville; A M Mackay
Journal: Br J Cancer Date: 1975-01 Impact factor: 7.640

4 in total